Thiamine deficiency in oncology: Clinical insights from two cases of Wernicke’s encephalopathy

Read full text Summarise with VIRAT
Authors: Ahmet Burak Ağaoğlu, Ferhat Ekinci, Atike Pınar Erdoğan, Mustafa Şahbazlar, Gonca Akdere ATEŞ
Cited by: 0
References: 14

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Wernicke's encephalopathy (WE) is a neurological disorder primarily caused by thiamine deficiency, typically presenting with malnutrition, confusion or delirium, oculomotor abnormalities (such as nystagmus or ophthalmoplegia), and ataxia. Although commonly associated with alcoholism, WE is frequently observed in oncology patients but is often under-recognised, leading to inadequate diagnosis and treatment. Malnutrition and rapid weight loss in cancer patients can increase the risk of this condition. We report two patients with cancer who presented with significant malnutrition and weight loss, leading to a diagnosis of WE. Both patients were diagnosed based on clinical presentation and magnetic resonance imaging, which is crucial for detecting neurological deficits. Immediate treatment with intravenous thiamine led to a positive clinical response. Early recognition and treatment of WE in oncology patients is essential, as the neurological deficits are potentially reversible. Intravenous thiamine supplementation, and supportive care, can prevent long-term complications.

Fields of Study & Subjects

Alcoholism and Thiamine Deficiency Autoimmune Neurological Disorders and Treatments Biochemical Acid Research Studies

Publication details

Journal / source
The National Medical Journal of India
Volume
39
Issue
5
Pages
312–314
Publication date
23 February 2026
Language
EN